Expertise in
55
conditions

Dr. Peter Karachunski

Pediatric Neurology
University Of Minnesota Masonic Children's Hospital
420 Delaware St SE, 
Minneapolis, MN 
Offers Telehealth
Expertise in
55
conditions
University Of Minnesota Masonic Children's Hospital
420 Delaware St SE, 
Minneapolis, MN 

Overview

Peter Karachunski is a Pediatric Neurologist in Minneapolis, Minnesota. Dr. Karachunski is highly rated in 55 conditions, according to our data. His top areas of expertise are Duchenne Muscular Dystrophy, Paramyotonia Congenita, Myotonic Dystrophy, and Myotonic Dystrophy Type 2.

His clinical research consists of co-authoring 29 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatric Neurology

Licenses

Child & Adolescent Psychiatry in MN

Hospital Affiliations

M Health Fairview University Of Mn

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avera Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

University of Minnesota Masonic Children's Hospital
420 Delaware St SE, Minneapolis, MN 55455
Other Locations
Fairview Health Services
2512 S 7th St, Minneapolis, MN 55454

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension
Enrollment Status: Completed
Publish Date: April 25, 2025
Intervention Type: Drug
Study Drug: Pitolisant
Study Phase: Phase 2
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Multicenter Open-Label Study on the Safety and Efficacy of Deflazacort (Emflaza) in Subjects With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
A Multicenter Open-Label Study on the Safety and Efficacy of Deflazacort (Emflaza) in Subjects With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
Enrollment Status: Terminated
Publish Date: June 27, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Drug
Study Phase: Phase 3
Phase 2 Clinical Pharmacology Study to Assess Dystrophin Levels in Subjects With nmDMD Before and After Treatment With Ataluren
Phase 2 Clinical Pharmacology Study to Assess Dystrophin Levels in Subjects With nmDMD Before and After Treatment With Ataluren
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

29 Total Publications

Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Journal: Journal of comparative effectiveness research
Published: August 22, 2025
Similar Doctors
Expertise in
8
conditions
Dr. Steven Janousek
Pediatric Neurology
Expertise in
8
conditions
Dr. Steven Janousek
Pediatric Neurology

Noran Neurology - Bloomington/Edina

3601 Minnesota Dr Ste 200, 
Minneapolis, MN 
 (8.6 miles away)
612-879-1500
Languages Spoken:
English
See accepted insurances

Steven Janousek is a Pediatric Neurologist in Minneapolis, Minnesota. Dr. Janousek is highly rated in 8 conditions, according to our data. His top areas of expertise are Susac Syndrome, Generalized Tonic-Clonic Seizure, Seizures, and Zika Virus Disease.

Expertise in
5
conditions
Dr. Namita Garg
Pediatric Neurology
Expertise in
5
conditions
Dr. Namita Garg
Pediatric Neurology

Gillette Children's

200 University Ave E, 
Saint Paul, MN 
 (6.5 miles away)
651-291-2848
Languages Spoken:
English
See accepted insurances

Namita Garg is a Pediatric Neurologist in Saint Paul, Minnesota. Dr. Garg is highly rated in 5 conditions, according to our data. Her top areas of expertise are Generalized Tonic-Clonic Seizure, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Seizures, and GAPO Syndrome.

Expertise in
10
conditions
Dr. Amy Catalfamo
Pediatric Neurology
Expertise in
10
conditions
Dr. Amy Catalfamo
Pediatric Neurology

Noran Neurology - Lake Elmo

8515 Eagle Point Blvd Ste 100, 
Lake Elmo, MN 
 (14.5 miles away)
612-879-1500
Languages Spoken:
English
See accepted insurances

Amy Catalfamo is a Pediatric Neurologist in Lake Elmo, Minnesota. Dr. Catalfamo is highly rated in 10 conditions, according to our data. Her top areas of expertise are Epilepsy Juvenile Absence, Migraine, Absence Seizure, and Seizures.

Frequently Asked Questions about Dr. Peter Karachunski

How do I make an appointment with Dr. Peter Karachunski?

You can book an appointment with Dr. Peter Karachunski by calling their office at 612-625-7466. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Peter Karachunski a top-rated expert for Duchenne Muscular Dystrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peter Karachunski is classified as an Distinguished expert for Duchenne Muscular Dystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Peter Karachunski specialize in?

While Dr. Peter Karachunski is a Pediatric Neurology, they have specific expertise in Duchenne Muscular Dystrophy, Paramyotonia Congenita, and Myotonic Dystrophy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Neurology.

Does Dr. Peter Karachunski participate in research or clinical trials?

Yes. Dr. Peter Karachunski has published 29 articles and abstracts on conditions like Duchenne Muscular Dystrophy. You can view a list of Dr. Peter Karachunski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Peter Karachunski accept my insurance?

Dr. Peter Karachunski accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-625-7466 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Karachunski's expertise for a condition
ConditionClose
    View All 14 Distinguished Conditions
    View All 41 Advanced Conditions
    View All 62 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile